SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. 1)
Filed by the Registrant [X]
Filed by a Party other than the Registrant
Check the appropriate box:
Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2)
Definitive Proxy Statement
[X] Definitive Additional Materials
Soliciting Material Pursuant to (S) 240.14a-11(c) or (S) 240.14a-12
CARRINGTON LABORATORIES, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] No fee required.
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
1) Title of each class of securities to which transaction applies:
2) Aggregate number of securities to which transaction applies:
3) Per unit price or other underlying value of transaction
computed pursuant to Exchange Act Rule 0-11 (set forth the amount on
which the filing fee is calculated and state how it was determined):
4) Proposed maximum aggregate value of transaction:
5) Total fee paid:
Fee paid previously with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
1) Amount Previously Paid:
2) Form, Schedule or Registration Statement No.:
3) Filing Party:
4) Date Filed:
<PAGE>
Carrington Laboratories, Inc.
2001 Walnut Hill Lane
Irving, Texas 75038
Phone: (972) 518-1300
May 5, 1997
Dear Shareholder:
Enclosed with this letter are the Notice of Annual Meeting of
Shareholders to be held on May 22, 1997, the related Proxy Statement and
proxy, and the 1996 Annual Report to Shareholders.
Due to unavoidable and unforseen delays, it was not possible to send the
enclosed items to shareholders on the date indicated in the second
paragraph on page 1 of the Proxy Statement, as we had planned at the
time the Proxy Statement was printed. Instead, the approximate date on
which all of these items are first being sent to shareholders is May 5,
1997.
We considered changing the date of the annual meeting but decided not to
do so for several reasons. Consequently, the period between the date on
which you are receiving the enclosed materials and the date of this
year's annual meeting is shorter than the notice period we normally try
to provide. We sincerely regret this fact and hope it does not cause
you any inconvenience.
In order to ensure the existence of a quorum and avoid the trouble and
expense of adjourning or postponing the meeting to a future date, it is
extremely important that you mark, date and sign the enclosed proxy and
return it promptly in the enclosed envelope. If you attend the meeting
in person, you may withdraw your proxy and vote in person, if you wish.
Sincerely,
Carlton E. Turner, Ph.D., D.Sc.
President/Chief Executive Officer
Enclosure
